Cancer Diagnostics

Fremont, California | April 13, 2026 Personalis, Inc. has unveiled new data showcasing its ultrasensitive ctDNA-based cancer monitoring platform,...

South San Francisco, California, March 16, 2026 Veracyte, Inc. announced the appointment of Kevin Haas, Ph.D., as Chief Development...

FOSTER CITY, Calif., March 3, 2026 Adela, Inc. has announced the publication of new clinical validation data in npj...

HYDERABAD, India, Feb. 16, 2026 — The University of Hyderabad and MNJ Institute of Oncology & Regional Cancer Centre...

HOUSTON, December 11, 2025 — Plus Therapeutics announced that its subsidiary CNSide Diagnostics, LLC has secured new state laboratory...

Boston, MA – December 2025 – The global Clinical Oncology Next-Generation Sequencing (NGS) market is expanding rapidly as cancer...

TORONTO, Sept. 2, 2025 – Geneseeq Technology Inc. announced that its GeneseeqPrime® NGS Tumor Profiling Assay has received 510(k)...